AIMS: This prospective registry study was intended to evaluate outcomes and predictors of adverse events following carotid artery stenting (CAS). METHODS AND RESULTS: @entity1 received neurological and duplex exams before CAS, prior to discharge and at 30- and 180-day follow-up. Multiple regression analysis included @entity1 - and procedure-related characteristics. The MACCE endpoint comprised @entity64 , @entity583 and @entity204 . Three hundred and seventy-five consecutive @entity1 underwent CAS between 1998 and 2011. Mean age was 69  9.1 years; 53% were symptomatic within the preceding six months. Mean time to CAS was 23 days in @entity1 with @entity4905 and 31 days with @entity64 (p=0.029). The MACCE rate was 1.6% during intervention and 4.0%, 5.6% and 5.9% at discharge, day 30 and day 180, respectively. @entity4905 occurred in 31 cases (9.6%) within 30 days. A history of @entity4905 was independently associated with MACCE (OR: 2.88; p=0.04). Furthermore, a history of hyperlipidaemia (OR: 4.02, p=0.029), MI (OR: 2.93, p=0.007) and age >= 70 (OR: 1.89, p=0.033) were independent predictors for the combined endpoint MACCE plus @entity4905 . CONCLUSIONS: @entity4905 is an underappreciated adverse event following CAS. Pre-procedural @entity4905 was an independent risk factor for adverse outcomes, while @entity64 was not, probably related to the timing of the procedure relative to the index event.

History of transient ischaemic attack, XXXX and hyperlipidaemia affects outcome following carotid artery stenting.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient'] @entity64 :: ('MESH:D020521', 'Disease') :: ['stroke'] @entity4905 :: ('MESH:D002546', 'Disease') :: ['TIA'] @entity583 :: ('MESH:D009203', 'Disease') :: ['myocardial infarction'] @entity204 :: ('MESH:D003643', 'Disease') :: ['death']
@entity583 :: (MESH:D009203,Disease) :: ['myocardial infarction']
